Speech-Language Pathologists in Bement, IL Accepting Medicare
2 Speech-Language Pathologists found. Showing 1 - 2
 Ms. Erin Anderson, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 201 S Champaign St, Bement, IL 61813 Phone: 217-678-4200 |
Lesley Lou Lieb, M.S. CCC-SLP/L Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1260 E 1100 North Rd, Bement, IL 61813 Phone: 217-520-4526 |
News Archive
Alkermes receives tentative schedule notification for FDA advisory committee meeting on VIVITROL sNDA
Alkermes, Inc. today announced that the U.S. Food and Drug Administration (FDA) has notified the company of the tentative scheduling of a Psychopharmacologic Drugs Advisory Committee meeting on September 16, 2010, for the review of the company's supplemental New Drug Application (sNDA) for VIVITROL® (naltrexone for extended-release injectable suspension) for opioid dependence.
Moderate caloric restriction in healthy non-obese individuals reduces chronic inflammation
Eating less may help us lead longer, healthier lives, according to the new results from a large, multicenter study, led by researchers at the Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University.
IPS examines potential for future U.N. population meeting
Inter Press Service examines the possibility of another U.N. conference on development and population within the next five years. Despite progress made since the 1994 conference on population and development (ICPD), U.N. Secretary-General Ban Ki-Moon recently noted more than 200 million women cannot access safe and effective contraception, and "too many women resort to unsafe abortions because they lack access to family planning," according to the news service.
UCI scientists create eight-layer, early-stage retina from human embryonic stem cells
UC Irvine scientists have created an eight-layer, early-stage retina from human embryonic stem cells, the first three-dimensional tissue structure to be made from stem cells.
Emergent BioSolutions receives NIAID funding support for dmPA7909 anthrax vaccine candidate
Emergent BioSolutions Inc. announced today that it was awarded a cooperative agreement from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, to further the development of one of Emergent's advanced anthrax vaccine candidates known as dmPA7909.
› Verified 2 days ago